/PRNewswire/ Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today renewed its commitment to increasing awareness and advancing care for people living with TD.
The state of Maryland is recognizing Tardive Dyskinesia (TD) Awareness Week, which runs May 1-7 this year. TD is a disorder that affects more than 600,000 Americans and is characterized by random, involuntary, and uncontrolled movements of different muscles in the face, trunk, and extremities.